Skip to content

Dr. Jonas Denduyver

Active Private limited companyfounded 2023active for 2 yearsEikenmolenwijk 26, 9820 Merelbeke-MelleKBO/BCE: BE 1003.285.450

Lifetime

2 annual accounts with figures on one time axis
peak of €116,773 in 2025
€116,773▲ 58.8%
peak of €86,635 in 2025
€86,635▲ 52.3%
peak of €144,522 in 2025
€144,522▲ 150%
€63,561▼ 23.1%
Board1 name since 2023
1 director
Documentsfilings and deeds
10-03-202651 days before the deadline
2025micro format
Gross margin from €73,521 to €116,773Result from €56,888 to €86,635Equity from €57,888 to €144,522Debts from €82,665 to €63,561Investments €5,854

Key points

from the 2025 annual accounts

Equity

€144,522 ▲ 150%
€57,9002024€145,0002025

Equity rose in 2025 from €57,888 to €144,522.

Investments

€5,854 2.0 times depreciation
20242025

Green is investment, beige is depreciation.

Liquidity

3.16 was 1.69 in 2024

Short-term debts fell from €80,755 to €63,561.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 39,329 companies had the same profile as Dr. Jonas Denduyver has now. Each dot stands for 99 companies, two years later.

95.7%
were still trading
2.4%
stopped another way
1.8%
went bankrupt
  • Micro
  • 2 to 5 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more

Another 0.1% stopped without a precise date, possibly only after those two years.

Test of the method

The method was tested on the 497,962 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 39,329 companies, not a prediction for Dr. Jonas Denduyver. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director
  • 50 sharesdeed of 14-12-2023
Board & ownership

Recent changes

Registered in the Peppol Directory Reachable for e-invoices through 0208:1003285450
Registered office moved from Ghent to Merelbeke The registered office moved from Langestraat 80, 9050 Gent to Eikenmolenwijk 26, 9820 Merelbeke · Board meeting of 01-05-2024 · Gazette deed
Incorporation Founded by · 50 shares · appointed as director · published on 14-12-2023 · Gazette deed
First establishment At the time the registered office was still in Gent, Langestraat 80.
All 7 events

Comparable companies

same main activity, similar in size and age
Company
Dr. Jonas Denduyver Merelbeke-Melle €208,083 €116,773 69.5% -
Dr. Lien Devuyst, NKO Ghent €214,276 €113,611 89.3% -
Dr. Caroline Hofmans Aalst €203,054 €129,801 83.7% -
MB Ortho Sint-Martens-Latem €202,299 €127,705 82.5% -
LR MEDICAL Liège €213,274 €117,176 95.4% -
HEMATHEM Auderghem €216,398 €114,754 97.3% -
Reunite Bruges €202,070 €119,464 86.3% -

These companies have the same main activity as Dr. Jonas Denduyver: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €202,000 and €216,000, founded between 2023 and 2024.

Official details

Source: KBO
Status
Active since 12-12-2023Normal situation
Activity
Specialist medical practiceNACE 86220and 2 others
Establishment unit
2.354.047.6669820 Merelbeke-Melle, registered on 12-12-2023
Financial year end
30 September
Peppol
Reachable since 08-11-2024
Company details

Annual accounts to 30-09-2025

≈ €220,000estimated
€208,083▲ 48.0%
Filing
Filed on 10-03-2026, 51 days before the end of the filing period
Financials

Insights on Dr. Jonas Denduyver

Dr. Jonas Denduyver has been active since 2023 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €144,522 and a net result of €86,635.

Its solvency ranks better than 57% of 21,347 sector peers (NACE 86) in financial year 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about Dr. Jonas Denduyver

What is the company number of Dr. Jonas Denduyver?
The company number of Dr. Jonas Denduyver is 1003.285.450. The VAT number is the same number with BE in front: BE 1003.285.450.
Where is Dr. Jonas Denduyver based?
The registered office is at Eikenmolenwijk 26, 9820 Merelbeke-Melle.Company details
What does Dr. Jonas Denduyver do?
According to the KBO register, the main activity is specialist medical practice (NACE 86220).
What is the legal form of Dr. Jonas Denduyver?
Dr. Jonas Denduyver is a private limited company (BV).
When was Dr. Jonas Denduyver founded?
Dr. Jonas Denduyver was founded on 12-12-2023.
Is Dr. Jonas Denduyver still active?
Yes, Dr. Jonas Denduyver is an active enterprise in the KBO register.
What is the turnover of Dr. Jonas Denduyver?
The turnover in financial year 2025 is ≈ €220,000. This figure is estimated from the gross margin of €116,773 and 40 comparable companies (NACE 86220). It probably lies between €180,000 and €290,000.Financials
Is Dr. Jonas Denduyver profitable?
In financial year 2025, Dr. Jonas Denduyver made a profit of €86,635.
Where can I find the annual accounts of Dr. Jonas Denduyver?
Dr. Jonas Denduyver filed 2 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of Dr. Jonas Denduyver due?
Dr. Jonas Denduyver must file the annual accounts for financial year 2026 by 30-04-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.